{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:59:30Z","timestamp":1785283170767,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jdcr.2026.01.042","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:02:02Z","timestamp":1770134522000},"page":"60-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mycosis fungoides progression following COVID-19 mRNA vaccination: A case series"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7846-2200","authenticated-orcid":false,"given":"Priyanka","family":"Kadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Ladrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4822-0534","authenticated-orcid":false,"given":"Brian","family":"Poligone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2026.01.042_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-021-00296-9","article-title":"Cutaneous T cell lymphoma","volume":"7","author":"Dummer","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.jdcr.2026.01.042_bib3","first-page":"221","article-title":"Efficacy and safety of COVID-19 vaccines: a systematic review","volume":"23","author":"Xing","year":"2021","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.jdcr.2026.01.042_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/jskc\/3103865","article-title":"Drug- and vaccine-induced cutaneous t-cell lymphoma: a systematic review of the literature","volume":"2025","author":"Etesami","year":"2025","journal-title":"J Skin Cancer"},{"key":"10.1016\/j.jdcr.2026.01.042_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1325478","article-title":"Rare COVID-19 vaccine side effects got lost in the shuffle. Primary cutaneous lymphomas following COVID-19 vaccination: a systematic review","volume":"11","author":"Olszewska","year":"2024","journal-title":"Front Med"},{"issue":"9","key":"10.1016\/j.jdcr.2026.01.042_bib6","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.immuni.2021.08.001","article-title":"Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination","volume":"54","author":"Painter","year":"2021","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.jdcr.2026.01.042_bib7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2326-6066.CIR-17-0270","article-title":"Primary T cells from cutaneous T-cell lymphoma skin explants display an exhausted immune checkpoint profile","volume":"6","author":"Querfeld","year":"2018","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"10.1016\/j.jdcr.2026.01.042_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00281-016-0594-9","article-title":"Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover","volume":"39","author":"Krejsgaard","year":"2017","journal-title":"Semin Immunopathol"},{"issue":"4","key":"10.1016\/j.jdcr.2026.01.042_bib9","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1111\/jdv.18806","article-title":"Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: a multicentre experience from tertiary referral hospitals","volume":"37","author":"Avallone","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jdcr.2026.01.042_bib10","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1111\/jdv.17736","article-title":"Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination","volume":"36","author":"Panou","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jdcr.2026.01.042_bib11","article-title":"New mycosis fungoides\u2013like lymphomatoid reaction following COVID-19 vaccination: a case report","volume":"10","author":"Li","year":"2022","journal-title":"SAGE Open Med Case Rep"},{"issue":"1","key":"10.1016\/j.jdcr.2026.01.042_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/10428194.2023.2270766","article-title":"Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes","volume":"65","author":"Gordon","year":"2023","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.jdcr.2026.01.042_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/medicina59010157","article-title":"Non-Hodgkin lymphoma developed shortly after mRNA COVID-19 vaccination: report of a case and review of the literature","volume":"59","author":"Cavanna","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jdcr.2026.01.042_bib14","article-title":"Rapid progression of marginal zone B-cell lymphoma after COVID-19 vaccination (BNT162b2): a case report","volume":"9","author":"Sekizawa","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.jdcr.2026.01.042_bib15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/bjd.20630","article-title":"Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination","volume":"185","author":"Gambichler","year":"2021","journal-title":"Br J Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262600055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262600055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:27:32Z","timestamp":1785281252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251262600055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":14,"alternative-id":["S235251262600055X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.01.042","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycosis fungoides progression following COVID-19 mRNA vaccination: A case series","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}